Compound Evidence File
#EC-2026-0653
Dianabol Oil
Filed under Injectable Oils. The bureau holds 141 laboratory returns for this compound from 56 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
56 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Jun 2026 | 1 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 25 Jan 2026 | 8 Aug 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 10.0 | 10.0 | 23 Apr 2026 | 12 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Jan 2026 | 18 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 27 Apr 2026 | 27 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Feb 2026 | 4 Apr 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 10.0 | 10.0 | 21 Dec 2025 | 13 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 4 May 2026 | 24 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 9 Apr 2026 | 7 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Jun 2026 | 8 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Apr 2026 | 5 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Nov 2025 | 22 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 4 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Jan 2026 | 7 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 21 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Nov 2025 | 2 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 13 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 20 Jan 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 8 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Jan 2026 | 13 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Jun 2026 | 7 Jul 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 | 17 Dec 2024 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 9.2 | 9.2 | 9.2 | 28 Mar 2025 | 28 Mar 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 9.1 | 8.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 9.1 | 8.7 | 9.6 | 24 May 2026 | 24 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 8.9 | 8.9 | 8.9 | 13 Feb 2025 | 13 Feb 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.7 | 6.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 5 | 8.0 | 5.0 | 9.8 | 6 May 2025 | 24 May 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 4 | 8.0 | 6.4 | 8.8 | 3 Jul 2025 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 7.9 | 6.8 | 8.9 | 23 May 2026 | 23 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 7.7 | 7.7 | 7.7 | 2 Jul 2025 | 2 Jul 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 7.4 | 6.0 | 9.3 | 23 May 2026 | 23 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.4 | 5.6 | 9.2 | 13 Jun 2025 | 23 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 | 16 Mar 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 7.3 | 6.7 | 7.7 | 24 Apr 2025 | 17 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 | 24 Apr 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 | 13 Jun 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 7.0 | 7.0 | 7.0 | 28 Mar 2025 | 28 Mar 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 | 13 Jun 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 6.6 | 6.6 | 6.6 | 13 Jun 2025 | 13 Jun 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 | 14 Jan 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 2 | 6.4 | 5.1 | 7.8 | 27 Feb 2025 | 21 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 4 | 6.3 | 5.2 | 7.8 | 13 Feb 2025 | 24 May 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 | 13 Jun 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 3 | 5.8 | 4.7 | 7.5 | 13 Feb 2025 | 20 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 1 | 5.8 | 5.8 | 5.8 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 | 3 Jul 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 5.0 | 5.0 | 5.0 | 9 Jun 2025 | 9 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 | 24 Apr 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 | 28 Mar 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 4.6 | 4.6 | 4.6 | 24 Apr 2025 | 24 Apr 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 4.5 | 4.5 | 4.5 | 16 Mar 2025 | 16 Mar 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 4.1 | 3.2 | 4.7 | 28 Mar 2025 | 25 May 2026 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
Open any subject to view the batch-level evidence for Dianabol Oil alone.